Healthcare Realty Trust stock upgraded by Scotiabank on growth outlook

Scotiabank upgraded Healthcare Realty Trust (HR) to Sector Outperform, raising its price target to $20.00, anticipating valuation expansion as the medical office building REIT returns to growth under new CEO Peter Scott. The firm projects 4% FFOPS and 5% AFFOPS growth by 2027, driven by balance sheet repair through asset sales and a 23% dividend cut aimed at funding redevelopment for future net operating income upside. Despite a significant Q2 EPS miss, the stock experienced a surge, reflecting investor optimism in the company's strategic direction and its attractive 5.49% dividend yield.

Analysis

Scotiabank has upgraded Healthcare Realty Trust (HR) to Sector Outperform, raising its price target to $20.00 from $18.00, signaling confidence in a strategic turnaround under new CEO Peter Scott. The upgrade is predicated on an anticipated return to growth, with the firm projecting 4% funds from operations per share (FFOPS) and 5% adjusted funds from operations per share (AFFOPS) growth by 2027. This positive outlook is underpinned by the company's strategy to repair its balance sheet through asset sales and reduced leverage. A key component of this plan is a recent 23% dividend cut, which, while reducing immediate shareholder returns, is intended to fund redevelopment projects aimed at generating future net operating income (NOI) upside. Despite this forward-looking optimism, the company reported a significant second-quarter earnings miss, with an EPS of -$0.45 against a forecast of -$0.0795, a surprise of -466.04%. However, the market appears to be discounting this past performance, as the stock has surged and delivered an 8.32% return over the last six months, suggesting investor focus is on the future strategic direction. Scotiabank's price target implies a 15.5x multiple on fiscal 2027 AFFOPS, indicating a long-term perspective on the stock's recovery.

Key Decisions for Investors

• Investors should weigh the forward-looking growth narrative, supported by Scotiabank's upgrade and the new CEO's strategy, against the significant execution risk highlighted by the recent Q2 EPS miss of -466.04%.
• Monitor the progress of planned asset sales and the deployment of capital from the 23% dividend cut into redevelopment projects, as these are the primary catalysts for achieving projected 2027 growth targets.
• While the current 5.49% dividend yield is attractive for income-focused portfolios, recognize that the investment thesis is a multi-year turnaround play, with valuation expansion contingent on successful execution over the medium term.